Abstract
Introduction
Presently no effective therapy is available for metastatic melanoma [1] . Although chemotherapeutic drugs could theoretically target all metastatic sites, current treatments do not provide significant therapeutic effects [2] . Treatment failure in metastatic melanoma is not only caused by an impressive array of cell survival pathways, but is also due to resistance to apoptotic stimuli including radio-and chemotherapy [2] .
Metastatic cancers including melanoma are frequently associated with increased resistance to apoptosis induced by various therapeutic modalities [3, 4] . Therefore, the success of systemic therapy for the treatment of metastatic melanoma is minimal [5] [6] [7] . Cancer chemotherapeutic efficacy is frequently impaired by either intrinsic or acquired tumour resistance to multiple, structurally unrelated therapeutic drugs with different mechanisms of action [8] . Thus [9] .
, the development of an alternative approach to overcome chemo-resistance of melanoma metastasis, complementary to current therapies, is urgently needed. Apoptosisrelated protein-1 (APR-1) also known as melanoma antigen gene H1 (MAGE H1) is identified by functional screening during CD95-mediated pathways to apoptosis
The p75 neurotrophin receptor (p75NTR) is a tumour necrosis factor receptor (TNFR) superfamily member that is expressed at high levels during embryogenesis and functions as a pro-apoptotic receptor during development of neuronal and non-neuronal tissues [10] [11] [12] . However, the expression of p75NTR in melanoma is widely documented [13] . The [14] [15] [16] .
In addition, the interaction of several members of MAGE protein family with the intracellular region of p75NTR has been reported [17] [18] [19] [18, 20] .
. Neurotrophin receptor-interacting MAGE homolog (NRAGE), a member of MAGE family has been shown to function as an adaptor protein that links p75NTR to c-Jun-N-terminal kinase (JNK) activation and subsequently mediates apoptosis

Thus, based on its similarity to NRAGE, we performed serial deletion mapping of APR-1 protein to investigate its interacting affinity for the intracellular region of p75NRT. In this study, we demonstrated the interaction of APR-1 protein with p75NTR via the juxtamembrane domain (JMD). This interaction was found to play an essential non-redundant role in the modulation of APR-1-induced apoptosis by a mechanism including the activation of apoptosisregulating kinase 1 (ASK1)-JNK/p38, and disruption of both NF-B and ERK pathways.
Materials and methods
Cell lines
The melanoma cell lines A375 and BLM were obtained from American Type Culture Collection (ATCC, Manassas, VA, USA). The cells were cultured in DMEM medium containing 10% foetal bovine serum, and 100 U/ml penicillin and 100 g/ml streptomycin.
Reagents and inhibitors
The inhibitor of ASK1 (thioredoxin) was from MERK (Haar, Germany) and the inhibitors of JNK (SP600125) and p38 (SB-203580) were from Biomol (Loerach, Germany).
Establishment of melanoma cell lines for tightly regulated expression of APR-1
The melanoma (A375-TetOn and BLM-TetOn) cells were generated using the Tet-On expression system (Clontech, Inc., Heidelberg, Germany) as described previously [21, 22] 
Flow cytometric analysis of apoptosis by annexin V/PI staining
The detection of apoptosis was performed as described [24, 25] 
Measurement of mitochondrial membrane potential (⌬⌿m) using JC-1
The loss of ⌬⌿m was assessed by flow cytometric analysis using JC-1 staining as described [21, 24] 
Staining of intracellular calcium
The intracellular calcium staining was performed as described previously [25] . [26] .
Determination of cell viability by counting using trypan blue. 
Cell lysis and subcellular fractionation
Total and nuclear cell extracts were prepared from both melanoma clones A375-APR-1 and BLM-APR-1 clones as described [21, 24, 27] . The preparations of mitochondrial and endoplasmic reticulum (ER) fractions were performed as described previously [25] . 
Electrophoretic mobility shift assay
The details of electrophoretic mobility shift assay (EMSA) have been described [26, 27] 
In vitro translation
The (Fig. 1B) or by direct counting using trypan blue staining (Fig. 1C) . (Fig. 1B) . Also, the role of mitochondria in APR-1-induced apoptosis was analysed. Flow cytometric analysis using JC-1 staining (Fig. 1C (Fig. 2D) (Fig. 3E) , suggesting that APR-1-induced apoptosis may be mediated by direct interaction of APR-1 with the JMD of p75NTR. (Fig. 2F ) demonstrated the efficiency of siRNA to knockdown the basal expression level of p75NR, although data obtained from cell counting using trypan blue staining (Fig. 2G) (Fig. 2F) 
Construction, cloning and production of recombinant proteins
Application of siRNAs
Although the addition of Dox to culture media does not influence the viability of the parental cells (A375 and BLM), the induction of APR-1 expression, in both A375-APR-1 and BLM-APR-1 was found to reduce markedly the cell viability in a time-dependent manner. Accordingly, the reduction of cell viability was noted at 12 hrs past treatment and increased thereafter to reach a maximum at 48 hrs in both cells (Fig. 1B, C).To check whether APR-1-induced melanoma cell death is mediated by an apoptotic mechanism, we confirmed APR-1-induced cell death by flow cytometry using annexin V/PI staining. Twenty four hours following the induction of APR-1 protein, both melanoma cells were stained with annexin V-FITC/PI and subjected for flow cytometric analysis. The induction of APR-1 protein was found to kill melanoma cells by an apoptotic mechanism as demonstrated by annexin V/PI staining
Suppression of APR-1-induced apoptosis of melanoma cells by the knockdown of p75NTR
Fig. 1 (A) Time-dependent induction of APR-1 protein in both A375-APR-1 and BLM-APR-2 cells. Both A375-APR-1 and BLM-APR-1 cells were allowed to grow in the absence or in the presence of Dox (10 ng/ml) for regulated time intervals up to 48 hrs. The cells were harvested and subjected to Western blot analysis using anti-APR-1 antibody. Time course experiment demonstrates APR-1-induced reduction of cell viability in both A375-APR-1 and BLM-APR-1 cells as assessed by MTT assay (B) or by direct counting using trypan blue staining (C). Both parental cell lines were used as control to assess the toxicity of Dox on melanoma cells. (D) Flow cytometric analysis using annexin V/PI staining demonstrates the induction of apoptosis in melanoma cells by the expression of APR-1 protein. (E) Flow cytometry using JC-1 staining shows the loss of ⌬⌿m by the induction of APR-1 protein. Cells with intact mitochondria displayed high red and high green fluorescence and appear in the upper right quadrant of the scatterplots. In contrast, cells that had lost their ⌬⌿m displayed high green and low red fluorescence and appear in the lower right quadrant. (F) Western blot analysis demonstrates AIF and cytochrome c release in both cytosolic and mitochondrial fractions. Tom 20 (mitochondrial marker) was used as specific control for the purity of mitochondrial fractions. (G) Western blot analysis demonstrates cleavage of caspase 9, caspase-3 and PARP by the induction of APR-1 protein in melanoma cells. ␤-actin was used as internal control for loading and transfer. Data are representative of three independent experiments.
Although no alteration was noted at the expression levels of JNK, p38 or ERK (Fig. 3A) , the induction of APR-1 protein was found to enhance the phosphorylation of both JNK and p38, and to inhibit the phosphorylation of ERK (Fig. 3A) . (Fig. 3B) , and ATF-2 (Fig. 3C) , and the suppression of the transcription factor ELK-1 (Fig. 3D) confirming APR-1-induced effects on both JNK/p38 and ERK pathways. (10 ng Fig. 4A) and BLM-APR-1 (Fig. 4B) cells. In addition, the inhibition of IB␣ phosphorylation by APR-1 in both A375-APR-1 (Fig. 4A) and BLM-APR-1 (Fig. 4B ) cells was correlated with the increase of the stability of IB␣ protein, an evidence for the inhibition of NF-B pathway. Also, EMSA assay (Fig. 4C and D) demonstrated that APR-1-induced inhibition of NF-B activity is time dependent. (Fig. 5B) 
Next, we analysed the DNA-binding activity of the transcription factors AP-1, p53, activating transcription factor (ATF) and ELK-1, possible physiological substrates of JNK, p38 and ERK pathways. The analysis of the DNA-binding activities of the transcription factors using EMSA demonstrated the © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 2 (A) Dot blots analysis of the interaction of APR-1 protein with TNFR1 human p75NTR, mouse p75NTR, FADD and rat p75NTR. A total of 5 g of glutathione S-transferase (GST)-TNFR1 (100.0 pmol), TNFR2 (111.0 pmol), human p75NTR (106.4 pmol), mouse p75NTR (106 pmol), FADD (92.6 pmol), TrKA (113.6 pmol), TrKB (113.6 pmol), TrKC (113.6 pmol), Fas 142.8 pmol), death domain (142.8 pmol), APR-1 (100 pmol), rat p75NTR (106 pmol) or GST (192.0 pmol) were diluted in PBS and blotted onto nitrocellulose membrane and subsequently incubated overnight with in vitro transcribed and translated [ 35 S] APR-1 protein. (B) Interaction of APR-1 with P75NTR. The total cell lysates prepared from A375-APR-1 and BLM-APR-1 before and after the induction of APR-1 protein were subjected for either electrophoresis (for the detection of APR-1 and P75NTR) or for co-immunoprecipitation (IP) with either anti-P75NTR antibody or with anti-APR-1 antibody. Western blotting of IP: p75NTR for APR-1 revealed the interaction of APR-1 to P75NTR, whereas Western blotting of IP: APR-1 for P75NTR revealed the interaction of P75NTR to APR-1. ␤-actin was used as internal control for loading and transfer. (C) Schematic diagram of the extracellular and intracellular domains of p75NTR. Transmembrane domain, JMD and death domain. (D) GST-P75NTR recombinant proteins 1-427aa (106.4 pmol), 1-341aa (135.1 pmol), 1-311aa (147 pmol), 1-274 aa (166 pmol), 275-340aa (694.3) and 341-427aa (526.2 pmol), were separated by SDS-PAGE, and blotted on PVDF membrane and probed with in vitro transcribed and translated [ 35 S] APR-1. The interaction of APR-1 with the P75NTR domains was detected by exposing the membrane to X-ray films. The coomassie-stained gel shows the amount and the position of P75NTR recombinant proteins (left panel). (E) GST-JMD and death domain of P75NTR were separated by SDS-PAGE, and blotted on PVDF membrane and probed with in vitro transcribed and translated [ 35 S] APR-1. The interaction of APR-1 with both domains was detected by exposing the membrane to X-ray films. The coomassie-stained gel shows the amount of both JMD and death domains (left panel). (F) Western blot analysis demonstrates the expression of APR-1 by the addition of Dox to the culture medium of BLM-APR-1, the knockdown of p75NTR by its
Inhibition of NF-B pathway in APR-1-expressing cells
To investigate the effect of APR-1 accumulation on NF-B pathway, we performed a time course experiments to show whether APR-1-induced effects on NF-B pathways are correlated with the induced level of APR-1 protein. Both A375-APR-1 and BLM-APR-1 cells were allowed to grow in the presence of Dox
Fig. 3 Activation of both JNK and p38, and inhibition of ERK pathways by the induction of APR-1 protein. (A) Western blot analysis of JNK, p38 and ERK pathways demonstrates the enhancement of JNK and p38, and inhibition of ERK phosphorylation by the induction of APR-1 protein, in BLM-APR-1 cells, is time dependent. Western blot (B): the analysis of the total cell lysates of A375-APR-1 and BLM-APR-1 cells using phospho-specific antibodies demonstrated the phosphorylation of both JNK and p38, and the inhibition of phospho-ERK by the induction of APR-1-expression. Whereas, rehybridization of the same blots with antibodies recognizing the total proteins of JNK, p38, and ERK showed no alteration at their expression levels by the induction of APR-1 protein. ␤-actin was used as internal control for loading and transfer. EMSA demonstrates the enhancement of the DNA-binding activities of the transcription factors AP-1 and p53 (C), and ATF-2 (D), and the inhibition of DNA-binding activity of the transcription factor ELK-1 (E) by the induction of APR-1 protein. Data are representative of three independent experiments performed separately. following the induction of APR-1 for 24 and 48 hrs by the addition of Dox to the culture medium of A375-APR-1 (
The induction of APR-1 protein in melanoma cells influences both pro-and anti-apoptotic factors
Next, we investigated the effect of APR-1 protein on both pro-and anti-apoptotic proteins, by the analysis of the expression levels of pro-apoptotic proteins (Bax and Bak), and the anti-apoptotic proteins (Mcl-1 and Bcl-xL), as well as the inhibitor of apoptosis (XIAP) and survivin proteins. Figure 5A demonstrates the induction of Bax, but not Bak expression, and the suppression of Mcl-1, XIAP and survivin in APR-1-expressing cells, suggesting the involvement of both pro-and anti-apoptotic proteins in the modulation of APR-1-induced apoptosis. In order to show the role of Bax protein in the context of APR-1-induced apoptosis, we analysed the subcellular localization of the pro-apoptotic protein Bax in both ER and mitochondrial fractions. Data obtained from Western blot analysis
APR-1-induced apoptosis of melanoma cells is mediated by Bax via ASK1-JNK/p38 pathway
To investigate the molecular mechanism of APR-1-induced Bax expression and to address the role of Bax in the context of APR-1-induced apoptosis of melanoma cells, both A375-APR-1 and BLM-APR-1 cells, were pre-treated with the inhibitors of ASK1 (thioredoxin) and JNK (SP600125) before induction of APR-1 expression for 24 hrs
, and the total cell lysates and nuclear extracts were prepared. Data obtained from EMSA (Fig. 6 ) demonstrated the inhibition of APR-1-induced AP-1 ( Fig. 6A and B) , p53 ( Fig. 6C and D) and ATF-2 ( Fig. 6E and F [28] . However, the involvement of MAGEs in the regulation of cell cycle progression [29] and apoptosis [18] Two parallel signalling pathways are coupled to p75NTR: one pathway leads to apoptosis [30] and the other pathway leads to survival [31] . The activation of p75NTR results in the activation of JNK and, in turn, to apoptotic cell death. However, this event 357 depends on the cell type and its differentiation state [29] . The outcome of p75NTR signalling is modified by the orchestration of several downstream adaptor proteins [10, 32] . Some adaptor proteins are associated with cell death such as neurotrophin receptor interaction factor and p75NTR-associated cell death executor, whereas others appear to promote cellular survival (Fas-associated phosphatase-1, receptor-interacting protein-2 and TNFR-associated factor 6) [32, 33] .
In [37] . [38] .
The identification of juxtamembrane region of p75NTR as an interacting domain for APR-1 was initially unexpected, because p75NTR contains a C-terminal death domain that has been shown to be relevant for apoptosis [39] . Death (Fig. 8) .
In
conclusion, we confirmed the pro-apoptotic function of APR-1 in melanoma-derived cells lines. APR-1 triggers apoptosis of melanoma cells through the interaction with the JMD of p75NTR
via a molecular mechanism including the activation of both JNK and p38, and disruption of both NF-B and ERK pathways. 
